Arteriovenous Fistula
Cross-source consensus on Arteriovenous Fistula from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Risks & contraindications
Other
Highlighted claims
- Stenotic lesions in arteriovenous fistulas are mainly caused by neointimal hyperplasia. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
- Fistuloplasty can treat fistula stenosis, but repeat intervention is often required. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
- Postintervention primary patency is approximately 60-70% at 6 months and 40-50% at 1 year. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
- CAD has a vascular access rationale related to arteriovenous fistula outcomes. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
- Future colchicine trials could test whether colchicine reduces restenosis after fistuloplasty or increases usable arteriovenous fistulas. — Colchicine and dialysis patients (CAD): protocol for a feasibility study